Close Menu

NEW YORK (GenomeWeb) – The GenomeWeb Index rose nearly 9 percent in July as stocks and indices rebounded from their Brexit-induced June falls on good earnings news and a surprise acquisition. July's performance reversed the half-percent dip the Index saw in June, with all but three companies showing stock gains for the month.

The Index outperformed the Dow Jones Industrial Average and the Nasdaq, which rose nearly 3 percent and 7 percent respectively. However, the GWDN Index underperformed the Nasdaq Biotechnology Index, which gained nearly 13 percent in July.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.